Scancell is a clinical stage, publicly listed, biopharmaceutical company that is leveraging its proprietary research, built up over many years of study of the human adaptive immune system, to generate truly novel vaccine and antibody medicines to treat significant unmet needs in cancer and infectious disease.
Scancell’s existing research laboratories are based within the Biodiscovery Institute at the University of Nottingham. In addition, the company is also expanding into new laboratory facilities on the Oxford Science Park, where activities will focus on translational research, support for the company’s clinical trial activities, and formulation and analytical development activities for its novel products.
At Scancell, we value a healthy work culture that motivates our employees. Our passion is to develop new therapies for difficult to treat diseases whilst simultaneously developing career opportunities for individuals. We aim to hire outstanding people at all levels within the company and offer competitive salaries and a range of comprehensive employee benefits. Successful candidates will be integrated into our multidisciplinary teams involved in the development of the company’s vaccine and antibody therapeutic products.